Trident Texofab Limited has submitted to exchange Newspaper Advertisement for Publication of Unaudited Financial Result for the Quarter and Nine Months ended on 31.12.2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
View original source (BSE India)Trident Texofab Ltd. on 6ix
In the deck
Story so far
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.12.2024
- Announcement under Regulation 30 (LODR)-Conversion of Securities
Earlier from Trident Texofab
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Trident Texofab Ltd. Press Release Feb 03 2025
- Integrated Filing (Financial)
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.12.2024
- Result-Financial Result For The Quarter And Nine Months Ended On 31.12.2024
Later from Trident Texofab
- Board Meeting Outcome for Meeting Of The Company Held On Monday, March 17, 2025
- Outcome Of Board Meeting Held On Monday, March 17, 2025
- Announcement under Regulation 30 (LODR)-Conversion of Securities
- Trident Texofab Ltd. Press Release Mar 17 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, March 20, 2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab